Wells Fargo lowered the firm’s price target on Clorox (CLX) to $117 from $125 and keeps an Equal Weight rating on the shares. The firm notes the company’s Q1 and FY26 guide were soft albeit amid fears that had built. Wells doesn’t expect much change to narrative here, awaiting needed improvement into the second half of the year and debates on underlying growth into FY27.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
